Start typing to retrieve search suggestions. When suggestions are available use up and down arrows to review and ENTER to select. Continue typing to refine.
Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

Yesafili 40 mg/ml Solution for injection in pre-filled syringe {equilateral_black_triangle}

Active Ingredient:
aflibercept
Company:  
Biocon Biologics See contact details
ATC code: 
S01LA05
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials Letters to HCPs
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Yesafili BRVO Patient Guide

BRVO patient support guide

{pdf_link}

Yesafili CNV Patient Guide

mCNV Yesafili patient guide

{pdf_link}

Yesafili CRVO Patient Guide

CRVO Yesafili patient guide

{pdf_link}

Yesafili DMO Patient Guide

DMO Yesafili Patient support guide

{pdf_link}

Yesafili Prescriber Guide

{healthcare_pro_orange} For Healthcare Professionals

Yesafili Prescriber Guide

{pdf_link}

Yesafili wetAMD Patient Guide

wetAMD Yesafili patient guide

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Biocon Biologics
Company image
Address
16 Great Queen Street, Covent Garden, London, WC2B 5AH
Medical Information e-mail
[email protected]
Telephone
0080008250910